← Leaderboards
Xianbin Yang
University Of Texas Med Br Galveston
$1,903,870
Attributed
$2,866,519
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $631.9K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,866,519 · 8
By mechanism
R44$1,945,804 · 2
R43$845,215 · 5
R03$75,500 · 1
Top collaborators
- Bernard Mark Evers4 shared
- Anil K Sood2 shared
- Ross Howard Durland1 shared
- Na Li1 shared
- Youli Zu1 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Partha S Sarkar$4,554,192
- Junji Iwahara$6,213,418
- Antonella Casola$13,102,050
- Ricardo Rajsbaum$9,241,897
- Lindsay Carmelita Reese$77,390
Others in their field
Top investigators on “Vertebral Column”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$183,220,795
- Peter J. Snyder · University Of Pennsylvania$31,880,265
- Anastassios G Pittas · Tufts Medical Center$31,052,547
- Ryohei Yasuda · Northwestern University$21,938,293
- Gareth R Howell · Jackson Laboratory$21,454,210
- Jeffrey Charles Lotz · University Of California San Francisco$20,300,756
Research focus
Vertebral ColumnSmall Business Innovation Research GrantModificationResistanceBaseReagentProtocols DocumentationNucleaseBiotechnologyMonomerBiochemicalRibonucleosidesIn VivoPropertyPharmaceutical PreparationsSolidGene SilencingPhosphorusPhosphorodithioic AcidProductionSuccessBiologicalCommercializationBinding (Molecular Function)
Grant awards (11)
Unified Process for the Discovery of Protein Biomarkers and their X-Aptamer Affinity Reagents$185,564
R43 · FY2018 · GM · contact PI
New Reagents for RNA-based Therapeutic Technologies$477,211
R44 · FY2014 · GM · contact PI
New Reagents for RNA-based Therapeutic Technologies$519,358
R44 · FY2013 · GM · contact PI
New Building Blocks for the Synthesis of Modified RNAs$180,115
R43 · FY2012 · GM · contact PI
New Reagents for Synthesis of High Potency siRNA$475,210
R44 · FY2011 · GM · contact PI
New Reagents for the Synthesis of Phosphorodithioate-Modified 2'-O-Methyl RNAs$156,729
R43 · FY2011 · GM · contact PI
New Reagents for Synthesis of High Potency siRNA$474,025
R44 · FY2010 · GM · contact PI
Optimize RNA-aptamer for Biomarker Molecule CD30$123,605
R43 · FY2009 · CA · contact PI
New Reagents for Synthesizing Nuclease-resistant siRNA$99,602
R43 · FY2009 · GM · contact PI
New Reagents for Synthesizing Nuclease-resistant siRNA$99,600
R43 · FY2008 · GM · contact PI
Combinatorial Selection of Beta-Catenin/T Cell Factor Pathway Inhibitors$75,500
R03 · FY2006 · CA · contact PI